Kratom and Opioids: What the Research Actually Says

Why This Page Exists

Search "kratom and opioids" and you'll get two kinds of results: pages selling it as a miracle cure, and pages treating it as a deadly street drug. Both are dishonest. I've used kratom daily for a decade and I run an affiliate site, so I have every incentive to hype it, which is exactly why I'm going to be careful here instead. The people asking this question often aren't casual shoppers. They're people in pain, or people trying to get off opioids, sometimes without easy access to a doctor, methadone clinic, or prescription. They deserve straight information and real options, not marketing and not a lecture.

So here's what the research actually shows, what it doesn't, and where to get help that works.

Why People Say They Use Kratom

The largest surveys of kratom users paint a consistent picture. In a 2020 Johns Hopkins study of 2,798 users (Garcia-Romeu et al., Drug and Alcohol Dependence):

• 91% reported using kratom to relieve pain
• 67% for anxiety
• 41% to reduce or manage opioid withdrawal

An earlier survey by Grundmann (2017, 8,049 respondents) found similar reasons: about 68% for pain and 66% for a mood or emotional condition. That's a lot of people independently reaching for the same plant for the same reasons.

But here's the honest caveat that the miracle-cure pages leave out: these are self-report surveys of self-selected users, some recruited through kratom-advocacy channels. They tell you why people say they use kratom and that many report low harm. They do not prove kratom treats pain or opioid use disorder. That's a different, higher bar that controlled clinical trials would have to clear, and they haven't. So the accurate statement is: many people use kratom to self-manage pain and withdrawal, not kratom is proven to treat either.

Is Kratom an Opioid? The Honest Pharmacology

Botanically, kratom (Mitragyna speciosa) is in the coffee family, not the opium poppy family. But that's a technicality that can mislead. Its main active compounds, mitragynine and 7-hydroxymitragynine, are partial agonists at the mu-opioid receptor, the same receptor classic opioids hit. According to the National Institute on Drug Abuse (NIDA), the effects "only partially compare to those of opioids."

Why does the "partial agonist" part matter? Because partial agonists produce a ceiling effect, and researchers are studying whether that gives kratom's alkaloids a different risk profile than full-agonist opioids like heroin or oxycodone. NIDA says these compounds may have lower addiction potential relative to opioids, but frames that as a possibility under study, not an established benefit. It's genuinely interesting science. It is not a green light. Because kratom acts on opioid receptors, it can and does cause physical dependence and withdrawal, and we cover that in detail on our is kratom an opioid and kratom dependence pages.

The Real Risks, Stated Plainly

An honest page names the downsides. The FDA and NIDA are clear that kratom carries real risks:

• Dependence and withdrawal. Regular use, especially at higher doses, can lead to tolerance and an opioid-like withdrawal when you stop. This is not "just a plant with no downside."
• Serious adverse events. The FDA has warned of liver toxicity, seizures, and substance use disorder, and notes kratom can cause sedation, nausea, constipation, and, in some cases, respiratory depression.
• Polydrug danger. Most kratom-associated deaths have involved other drugs or contaminants. Mixing kratom with opioids, benzodiazepines, or alcohol is genuinely dangerous.
• Contamination and concentrated products. Untested products have been linked to salmonella, and concentrated 7-OH products are a distinct, higher-risk category now facing federal scheduling (see our 7-OH tracker). If you use kratom, third-party lab-tested plain leaf from a GMP-certified vendor is the lower-risk end of the spectrum.

The Access Problem Nobody Talks About

Here's the reality that makes this topic complicated. Evidence-based treatment for opioid use disorder exists and works, but a lot of people can't easily reach it. Methadone in the US is dispensed only through certified clinics that many rural counties don't have. Buprenorphine access has improved but still runs into provider shortages, cost, stigma, and insurance gaps. And people with genuine chronic pain sometimes find their prescriptions cut off with nowhere to turn. That gap is exactly why so many people end up self-managing with whatever is legal and available.

I'm not going to pretend that gap doesn't exist, and I'm not going to tell someone in it that their choices are simple. What I will do is make sure you know that the treatment options are real, effective, and worth pursuing, because the data on them is not close.

Medication for Opioid Use Disorder Is Not "Trading One Addiction for Another"

This is the part I most want to get right, because there's a popular myth, and I understand why it's appealing, that going from opioids (or kratom) onto methadone or Suboxone is just swapping one dependence for a stronger one, so why bother. I have to be straight with you: the evidence says that myth is wrong, and believing it can be fatal.

Methadone and buprenorphine (the active drug in Suboxone) are FDA-approved medications for opioid use disorder (MOUD). A large NIH-funded study of over 17,000 overdose survivors (Larochelle et al., Annals of Internal Medicine, 2018) found that in the year after an overdose:

• Methadone was associated with 59% lower opioid-overdose death
• Buprenorphine was associated with 38% lower opioid-overdose death

Those are enormous reductions in dying. SAMHSA, NIDA, and the CDC all consider MOUD first-line, life-saving treatment. Yes, these medications create physical dependence, but physical dependence is not the same thing as the chaos, overdose risk, and life disruption of active opioid use disorder. Buprenorphine is even a partial agonist, mechanistically closer to how kratom's alkaloids work than to a full-agonist opioid, but it's dosed, regulated, and clinically supervised. The point of treatment isn't to make you "drug-free" on paper. It's to keep you alive and functional. Whether MOUD is right for you is a decision to make with a clinician, but it deserves to be on the table, not dismissed by a myth.

If You're Going to Use Kratom Anyway

Plenty of people will read all of the above and still choose to use kratom. I'm not here to shame that, I'm one of them. But if that's your choice, do it at the lower-risk end:

• Buy plain leaf, third-party lab-tested, from a GMP-certified vendor. Not gas-station product, not untested concentrates. See our vendor guide and how to read a COA.
• Use as little as needed. The American Kratom Association's own consumer guidance is that dependence is more likely at higher doses and frequent use. Bigger doses and daily use are how a manageable habit becomes a hard-to-quit one.
• Avoid concentrated 7-OH products. They're a different, higher-risk category and the target of 2026 federal scheduling.
• Never mix kratom with opioids, benzodiazepines, alcohol, or other sedatives.
• Know how to stop. If you want to cut back or quit, we have a dedicated, resource-first guide: quitting or cutting back on kratom.

The Bottom Line

Kratom is neither a miracle nor a menace. Many people genuinely use it to manage pain and to get through opioid withdrawal, and the surveys are real, but "people use it for X" is not the same as "it's proven to treat X," and it carries real dependence risk. If you're dealing with opioid dependence, the single most important thing on this page is that evidence-based treatment exists and dramatically reduces your risk of dying, and it's worth pursuing even when access is hard. Whatever you decide, decide it with real information and, ideally, a clinician in your corner.

Sources

• Garcia-Romeu A, et al. Kratom user demographics and use patterns. Drug and Alcohol Dependence, 2020 (Johns Hopkins; n=2,798).
• Grundmann O. Patterns of kratom use and health impact in the US. Drug and Alcohol Dependence, 2017 (n=8,049).
• National Institute on Drug Abuse (NIDA), Kratom research topic.
• U.S. Food & Drug Administration, FDA and Kratom.
• Larochelle MR, et al. MOUD and mortality after opioid overdose. Annals of Internal Medicine, 2018 (via NIH).
• SAMHSA National Helpline; 988 Lifeline; FindTreatment.gov.

Disclaimer: This article is for general information for adults 21+ and is not medical advice. Kratom is not FDA-approved for any use. Talk to a licensed healthcare professional before starting, changing, or stopping any substance or treatment, especially if you take other medications or have a health condition.